Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05962424
PHASE1
HNC: Human Neural Circuits Electrophysiology During Cognition
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2023-10-05
Completion Date
2030-09-01
Last Updated
2025-08-26
Healthy Volunteers
No
Conditions
Interventions
DRUG
Ketamine Hydrochloride
Ketamine is an FDA-approved dissociative anesthetic.
Locations (1)
Stanford University
Palo Alto, California, United States